MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R

Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer

Tony Mok, Yi‐Long Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2016 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +16

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Kari Fischer, Anna Durrans, Sharrell Lee et al. · Nature · 2015 · 1.8K citations

Medicine, Cell Biology, Oncology +14

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

Chi Lam Au Yeung, Ngai-Na Co, Tetsushi Tsuruga et al. · Nature Communications · 2016 · 789 citations · Full text

Medicine, Cancer Biology, Oncology +17

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 529 citations

Medicine, Oncology, Pharmacology +10

Targeting BMI1 + Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma

Demeng Chen, Man-Si Wu, Li Yang et al. · Cell stem cell · 2017 · 287 citations · Full text

Medicine, Cancer Biology, Oncology +14